Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review

PurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center....

Full description

Bibliographic Details
Main Authors: Dimin Zhu, Zongming Wang, Tian Tian, Xinyi Wu, Dongsheng He, Yonghong Zhu, Dawei Liu, Haijun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/full
_version_ 1811284028872982528
author Dimin Zhu
Zongming Wang
Tian Tian
Xinyi Wu
Dongsheng He
Yonghong Zhu
Dawei Liu
Haijun Wang
author_facet Dimin Zhu
Zongming Wang
Tian Tian
Xinyi Wu
Dongsheng He
Yonghong Zhu
Dawei Liu
Haijun Wang
author_sort Dimin Zhu
collection DOAJ
description PurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center. Case reports of such tumors were also collected through a literature search. Clinical data such as biochemical tests, imaging examinations, and pathological data of the above cases were analyzed.ResultsA total of 101 T-PIT-positive patients were treated in our center in the last 2 years, and 4 were finally pathologically diagnosed with Crooke’s cell adenomas. All of these patients were male with elevated adrenocorticotropic hormone levels, and 50.0% presented with hypercortisolemia, Cushing’s syndrome, visual impairment, and headache. The tumor diameter was significantly larger in these 4 patients (37.0 mm) than in the other patients (26.0 mm), and their tumor invasive behavior was more pronounced. Cases reported in the literature were mainly female (72.8%), and the clinical presentation was also dominated by Cushing’s syndrome (65.1%) and hormonal dysfunction. Tumors were more common as macroadenomas (33.2 mm) and suprasellar growths (63.8%). The tumor recurrence rate was as high as 55.6%, with 6 cases progressing to pituitary carcinomas and 7.7% of tumor-related deaths. Our further integrated analysis of our center and reported cases revealed that gender, Cushing’s syndrome, visual dysfunction, hormonal disorders, and tumor growth characteristics were statistically different in different tumor categories.ConclusionCrooke’s cell adenoma is a tumor subtype with obvious clinical aggressive behavior, and an in-depth analysis of its clinical characteristics may assist in developing a comprehensive treatment plan.
first_indexed 2024-04-13T02:22:31Z
format Article
id doaj.art-e51f5b17ddf64af9bc4815a95641ef59
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T02:22:31Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-e51f5b17ddf64af9bc4815a95641ef592022-12-22T03:06:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-08-011310.3389/fendo.2022.947085947085Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature reviewDimin Zhu0Zongming Wang1Tian Tian2Xinyi Wu3Dongsheng He4Yonghong Zhu5Dawei Liu6Haijun Wang7Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaPurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center. Case reports of such tumors were also collected through a literature search. Clinical data such as biochemical tests, imaging examinations, and pathological data of the above cases were analyzed.ResultsA total of 101 T-PIT-positive patients were treated in our center in the last 2 years, and 4 were finally pathologically diagnosed with Crooke’s cell adenomas. All of these patients were male with elevated adrenocorticotropic hormone levels, and 50.0% presented with hypercortisolemia, Cushing’s syndrome, visual impairment, and headache. The tumor diameter was significantly larger in these 4 patients (37.0 mm) than in the other patients (26.0 mm), and their tumor invasive behavior was more pronounced. Cases reported in the literature were mainly female (72.8%), and the clinical presentation was also dominated by Cushing’s syndrome (65.1%) and hormonal dysfunction. Tumors were more common as macroadenomas (33.2 mm) and suprasellar growths (63.8%). The tumor recurrence rate was as high as 55.6%, with 6 cases progressing to pituitary carcinomas and 7.7% of tumor-related deaths. Our further integrated analysis of our center and reported cases revealed that gender, Cushing’s syndrome, visual dysfunction, hormonal disorders, and tumor growth characteristics were statistically different in different tumor categories.ConclusionCrooke’s cell adenoma is a tumor subtype with obvious clinical aggressive behavior, and an in-depth analysis of its clinical characteristics may assist in developing a comprehensive treatment plan.https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/fullCrooke’s cellpituitary adenomaACTHCushing diseasehyalinization
spellingShingle Dimin Zhu
Zongming Wang
Tian Tian
Xinyi Wu
Dongsheng He
Yonghong Zhu
Dawei Liu
Haijun Wang
Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
Frontiers in Endocrinology
Crooke’s cell
pituitary adenoma
ACTH
Cushing disease
hyalinization
title Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
title_full Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
title_fullStr Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
title_full_unstemmed Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
title_short Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
title_sort prevalence and clinical characteristics of crooke s cell adenomas in 101 patients with t pit positive pituitary adenomas case series and literature review
topic Crooke’s cell
pituitary adenoma
ACTH
Cushing disease
hyalinization
url https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/full
work_keys_str_mv AT diminzhu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT zongmingwang prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT tiantian prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT xinyiwu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT dongshenghe prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT yonghongzhu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT daweiliu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview
AT haijunwang prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview